Hye Won Lee

8PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 02, 2026
Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial.

|Jun 21, 2023
Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies.

Kyung Hwan Kim, Hye Won Lee, Hong Koo Ha

|Nov 04, 2020
Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts.

Kyoungmin Lee, Harim Koo, Yejin Kim

|Mar 12, 2020
Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity.

Hye Won Lee, Yun Shin Chung, Tae Jin Kim

|Aug 31, 2018
Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.

Ji Yeon Son, Sungpil Yoon, In Hwan Tae

|Aug 17, 2018
In vivo distribution of U87MG cells injected into the lateral ventricle of rats with spinal cord injury.

Jeong-Seob Won, Hyun Nam, Hye Won Lee

Pageof 2

Frequent Collaborators

3 joint publications

Ho Kyung Seo

1 joint publications

Hwang Gyun Jeon

1 joint publications

Byong Chang Jeong

1 joint publications

Seong Il Seo